{"paper_id":"23083cfb-d249-4ea7-93f1-ab9dab203602","body_text":"Abstract\nEndometriosis in adolescents needs unique considerations for treatment approaches, as it presents particular challenges in terms of diagnosis, variable presentation and symptoms, and choice of treatment [1]. Dysmenorrhea is the most common gynecologic issue among adolescents, occurring in 50–80% of these and causing limitation in sports and activities, poor academic performance, and long duration of resting (Fig. 6.1). In about 10% of adolescents with severe dysmenorrhea symptoms, pelvic abnormalities such as endometriosis or uterine anomalies may be found and the incidence of endometriosis has been reported between 45% and 70% in adolescents with chronic pelvic pain (CPP) [2].\nAccess this chapter\nTax calculation will be finalised at checkout\nPurchases are for personal use only\nSimilar content being viewed by others\nReferences\nBenagiano G, Guo SW, Puttemans P, Gordts S, Brosens I. Progress in the diagnosis and management of adolescent endometriosis: an opinion. Reprod BioMed Online. 2018;36:102–14.\nDun EC, Kho KA, Morozov VV, Kearney S, Zurawin JL, Nezhat CH. Endometriosis in adolescents. JSLS. 2015;19:e2015.00019.\nSieberg CB, Lunde CE, Borsook D. Endometriosis and pain in the adolescent striking early to limit suffering: a narrative review. Neurosci Biobehav Rev. 2020;108:866–76.\nVercellini P, Buggio L, Frattaruolo MP, Borghi A, Dridi D, Somigliana E. Medical treatment of endometriosis-related pain. Best Pract Res Clin Obstet Gynaecol. 2018;51:68–91.\nJohnson NP, Hummelshoj L, Adamson GD, et al. World endometriosis society consensus on the classification of endometriosis. Hum Reprod. 2017;32:315–24.\nSeyhan A, Ata B, Uncu G. The impact of endometriosis and its treatment on ovarian reserve. Semin Reprod Med. 2015;33:422–8.\nLiu X, Long Q, Guo SW. Surgical history and the risk of endometriosis: a hospital-based case-control study. Reprod Sci. 2016;23:1217–24.\nSibiude J, Santulli P, Marcellin L, Borghese B, Dousset B, Chapron C. 2014. Association of history of surgery for endometriosis with severity of deeply infiltrating endometriosis. Obstet. Gynecologie. 2014;124:709–917.\nZhang Q, Duan J, Olson M, Fazleabas A, Guo SW. Cellular changes consistent with epithelial-mesenchymaltransition and fibroblast-to-myofibroblast transdifferentiation in the progression of experimental endometriosis in baboons. Reprod Sci. 2016;23:1409–21.\nUnger CA, Laufer MR. Progression of endometriosis in nonmedically managed adolescents: a case series. J Pediatr Adolesc Gynecol. 2011;24:e21–3.\nStuparich MA, Donnellan NM, Sanfilippo JS. Endometriosis in the adolescent patient. Semin Reprod Med. 2017;35:102–9.\nSteenberg CK, Tanbo TG, Qvigstad E. Endometriosis in adolescence: predictive markers and management. Acta Obstet Gynecol Scand. 2013;92:491–5.\nShim JY, Laufer MR. Adolescent endometriosis: an update. J Pediatr Adolesc Gynecol. 2020;33(2):112–9.\nKaser DJ, Laufer MR. Norethindrone acetate for hormonal suppression of adolescent endometriosis-associated pain. J Pediatr Adolesc Gynecol. 2011;24:e49.\nYoost J, LaJoie AS, Hertweck P, et al. Use of the levonoresgetrel intrauterine system in adolescents with endometriosis. J Pediatr Adolesc Gynecol. 2013;26:120.\nSchindler AE, Henkel A, Moore C, Oettel M. Effect and safety of high-dose dienogest (20 mg/day) in the treatment of women with endometriosis. Arch Gynecol Obstet. 2010;282:507–14.\nEbert AD, Dong L, Merz M, et al. Dienogest 2 mg daily in the treatment of adolescents with clinically suspected endometriosis: the VISanne study to assess safety in ADOlescents. J Pediatr Adolesc Gynecol. 2017;30:560–7.\nSadler Gallagher J, Feldman HA, Stokes NA, et al. The effects of gonadotropin-releasing hormone agonist combined with add-back therapy on quality of life for adolescents with endometriosis: a randomized controlled trial. J Pediatr Adolesc Gynecol. 2017;30:215.\nTaylor HS, Giudice LC, Lessey BA, et al. Treatment of endometriosis-associated pain with Elagolix, an oral GnRH antagonist. N Engl J Med. 2017;377:28.\nTosti C, Biscione A, Morgante G, et al. Hormonal therapy for endometriosis: from molecular research to bedside. Eur J Obstet Gynecol Reprod Biol. 2017;209:61–6.\nWeng Q, Ding Z, Lv X, et al. Chinese medicinal plants for advanced endometriosis after conservative surgery: a prospective, multicenter, controlled trial. Int J Clin Exp Med. 2015;8:11307–11.\nPinho-Ribeiro FA, Verri WA Jr, Chiu IM. Nociceptor sensory neuron-immune interactions in pain and inflammation. Trends Immunol. 2017;38:5–19.\nSymons LK, Miller JE, Kay VR, et al. The immunopathophysiology of endometriosis. Trends Mol Med. 2018;24:748–62.\nGómez R, Abad A, Delgado F, Tamarit S, Simón C, Pellicer A. Effects of hyperprolactinemia treatment with the dopamine agonist quinagolide on endometriotic lesions in patients with endometriosis-associated hyper-prolactinemia. Fertil Steril. 2011;95:882–8.\nLi X, Liu X, Guo SW. Histone deacetylase inhibitors as therapeutics for endometriosis. Expert Rev Obstet Gynecol. 2014;7:451–66.\nHarel Z. Dysmenorrhea in adolescents and young adults: etiology and management. J Pediatr Adolesc Gynecol. 2006;19:363–71.\nMama ST. Advances in the management of endometriosis in the adolescent. Curr Opin Obstet Gynecol. 2018;30:326–30.\nSmorgick N, As-Sanie S, Marsh CA, Smith YR, Quint EH. Advanced stage endometriosis in adolescents and young women. J Pediatr Adolesc Gynecol. 2014;27:320–3.\nMatalliotakis M, Goulielmos GN, Matalliotaki C, et al. Endometriosis in adolescents and young girls: report of a series of 85 cases. J Pediatr Adolesc Gynecol. 2017;30:568.\nAudebert A, Lecointre L, Afors K, Koch A, Wattiez A, Akladios C. Adolescent endometriosis: report of a series of 55 cases with a focus on clinical presentation and long-term issues. J Minim Invasive Gynecol. 2015;22:834–40.\nSanfilippo JS, Mansuria SM, Donnellan NM. Surgical problems in the pediatric patient. In: Bieber EJ, Sanfilippo JS, Horowitz IR, Shafi MI, editors. Clinical gynecology. 2nd ed. Cambridge, UK: Cambridge University Press; 2015. p. 576–8.\nHogg S, Vyas S. Endometriosis update. Obstet Gynaec Repro Med. 2017;28:61–9.\nHealey M, Ang C, Cheng C. Surgical treatment of endometriosis: a prospective randomized double-blinded trial comparing excision and ablation. Fertil Steril. 2010;94:2536e40.\nLaufer MR, Einarsson JI. Surgical management of superficial peritoneal adolescent endometriosis. J Pediatr Adolesc Gynecol. 2019;32:339.\nSaridogan E. Adolescent endometriosis. Eur J Obstet Gynecol Reprod Biol. 2017;209:46–9.\nYeung J, Sinervo K, Winer W, et al. Complete laparoscopic excision of endometriosis in teenagers: is postoperative hormonal suppression necessary? Fertil Steril. 2011;95:1909–12.\nRimbach S, Ulrich U, Schweppe KW. Surgical therapy of endometriosis: challenges and controversies. Geburtshilfe Frauenheilkd. 2013;73:918–23.\nRoman JD. Adolescent endometriosis in the Waikato region of New Zealand–a comparative cohort study with a mean follow-up time of 2.6 years. Aust N Z J Obstet Gynaecol. 2010;50:179–83.\nTandoi I, Somigliana E, Riparini J, Ronzoni S, Vigano P, Candiani M. High rate of endometriosis recurrence in young women. J Pediatr Adolesc Gynecol. 2011;24:376–9.\nYang Y, Wang Y, Yang J, Wang S, Lang J. Adolescent endometriosis in China: a retrospective analysis of 63 cases. J Pediatr Adolesc Gynecol. 2012;25:295–9.\nShakiba K, Bena JF, McGill KM, Minger J, Falcone T. Surgical treatment of endometriosis: a 7-year follow-up on the requirement for further surgery. Obstet Gynecol. 2008;111:1285–92.\nWattier JM. Conventional analgesics and non-pharmacological multidisciplinary therapeutic treatment in endometriosis: CNGOF-HAS endometriosis guidelines. Gynecol Obstet Fertil Senol. 2018;46:248–55.\nMira TAA, Buen MM, Borges MG, et al. Systematic review and meta-analysis of complementary treatments for women with symptomatic endometriosis. Int J Gynaecol Obstet. 2018;143:2.\nConflict of Interest\nNone.\nFinancial Support\nNone.\nAuthor information\nAuthors and Affiliations\nCorresponding author\nEditor information\nEditors and Affiliations\nRights and permissions\nCopyright information\n© 2021 International Society of Gynecological Endocrinology\nAbout this chapter\nCite this chapter\nTroìa, L., Biscione, A., Colombi, I., Luisi, S. (2021). Management of Endometriosis in Teenagers. In: Genazzani, A.R., Nisolle, M., Petraglia, F., Taylor, R.N. (eds) Endometriosis Pathogenesis, Clinical Impact and Management. ISGE Series. Springer, Cham. https://doi.org/10.1007/978-3-030-57866-4_6\nDownload citation\nDOI: https://doi.org/10.1007/978-3-030-57866-4_6\nPublished:\nPublisher Name: Springer, Cham\nPrint ISBN: 978-3-030-57865-7\nOnline ISBN: 978-3-030-57866-4\neBook Packages: MedicineMedicine (R0)","source_license":"CC0","license_restricted":false}